In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.

A chemical inhibition model of inflammation is proposed by semi-continuous monitoring the density of toll-like receptor 1 (TLR1) expressed on mammalian cells following bacterial infection to investigate an in vivo-mimicked drug screening system. The inflammation was induced by adding bacterial lysat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jin-Woo Jeon, Un-Hwan Ha, Se-Hwan Paek
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3a6e3369db3042cc983bfebb5de0e5c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3a6e3369db3042cc983bfebb5de0e5c4
record_format dspace
spelling oai:doaj.org-article:3a6e3369db3042cc983bfebb5de0e5c42021-11-25T06:04:11ZIn vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.1932-620310.1371/journal.pone.0105212https://doaj.org/article/3a6e3369db3042cc983bfebb5de0e5c42014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25136864/?tool=EBIhttps://doaj.org/toc/1932-6203A chemical inhibition model of inflammation is proposed by semi-continuous monitoring the density of toll-like receptor 1 (TLR1) expressed on mammalian cells following bacterial infection to investigate an in vivo-mimicked drug screening system. The inflammation was induced by adding bacterial lysate (e.g., Pseudomonas aeruginosa) to a mammalian cell culture (e.g., A549 cell line). The TLR1 density on the same cells was immunochemically monitored up to three cycles under optimized cyclic bacterial stimulation-and-restoration conditions. The assay was carried out by adopting a cell-compatible immunoanalytical procedure and signal generation method. Signal intensity relative to the background control obtained without stimulation was employed to plot the standard curve for inflammation. To suppress the inflammatory response, sodium salicylate, which inhibits nuclear factor-κB activity, was used to prepare the standard curve for anti-inflammation. Such measurement of differential TLR densities was used as a biosensing approach discriminating the anti-inflammatory substance from the non-effector, which was simulated by using caffeic acid phenethyl ester and acetaminophen as the two components, respectively. As the same cells exposed to repetitive bacterial stimulation were semi-continuously monitored, the efficacy and toxicity of the inhibitors may further be determined regarding persistency against time. Therefore, this semi-continuous biosensing model could be appropriate as a substitute for animal-based experimentation during drug screening prior to pre-clinical tests.Jin-Woo JeonUn-Hwan HaSe-Hwan PaekPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 8, p e105212 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jin-Woo Jeon
Un-Hwan Ha
Se-Hwan Paek
In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
description A chemical inhibition model of inflammation is proposed by semi-continuous monitoring the density of toll-like receptor 1 (TLR1) expressed on mammalian cells following bacterial infection to investigate an in vivo-mimicked drug screening system. The inflammation was induced by adding bacterial lysate (e.g., Pseudomonas aeruginosa) to a mammalian cell culture (e.g., A549 cell line). The TLR1 density on the same cells was immunochemically monitored up to three cycles under optimized cyclic bacterial stimulation-and-restoration conditions. The assay was carried out by adopting a cell-compatible immunoanalytical procedure and signal generation method. Signal intensity relative to the background control obtained without stimulation was employed to plot the standard curve for inflammation. To suppress the inflammatory response, sodium salicylate, which inhibits nuclear factor-κB activity, was used to prepare the standard curve for anti-inflammation. Such measurement of differential TLR densities was used as a biosensing approach discriminating the anti-inflammatory substance from the non-effector, which was simulated by using caffeic acid phenethyl ester and acetaminophen as the two components, respectively. As the same cells exposed to repetitive bacterial stimulation were semi-continuously monitored, the efficacy and toxicity of the inhibitors may further be determined regarding persistency against time. Therefore, this semi-continuous biosensing model could be appropriate as a substitute for animal-based experimentation during drug screening prior to pre-clinical tests.
format article
author Jin-Woo Jeon
Un-Hwan Ha
Se-Hwan Paek
author_facet Jin-Woo Jeon
Un-Hwan Ha
Se-Hwan Paek
author_sort Jin-Woo Jeon
title In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
title_short In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
title_full In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
title_fullStr In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
title_full_unstemmed In vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
title_sort in vitro inflammation inhibition model based on semi-continuous toll-like receptor biosensing.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/3a6e3369db3042cc983bfebb5de0e5c4
work_keys_str_mv AT jinwoojeon invitroinflammationinhibitionmodelbasedonsemicontinuoustolllikereceptorbiosensing
AT unhwanha invitroinflammationinhibitionmodelbasedonsemicontinuoustolllikereceptorbiosensing
AT sehwanpaek invitroinflammationinhibitionmodelbasedonsemicontinuoustolllikereceptorbiosensing
_version_ 1718414215611416576